• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of the influence of the oral environment on the development and recurrence of head and neck and esophageal cancer

Research Project

Project/Area Number 19K18956
Research Category

Grant-in-Aid for Early-Career Scientists

Allocation TypeMulti-year Fund
Review Section Basic Section 57020:Oral pathobiological science-related
Research InstitutionHokkaido University

Principal Investigator

Nakatsumi Hiroshi  北海道大学, 医学研究院, 客員研究員 (50735157)

Project Period (FY) 2019-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2021: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2020: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywordsアセトアルデヒド / ALDH2 / 食道癌 / 頭頸部癌 / 頭頸部・食道癌 / 口内環境 / 発生・再発 / 口腔内細菌叢 / 口腔内代謝産物
Outline of Research at the Start

近年、口腔内細菌叢が多量のアセトアルデヒドを産生するとの報告がされているが、頭頸部・食道癌の発生および再発におよぼす影響、またアセトアルデヒドのみならず口腔内細菌による代謝産物の影響についても十分な解析がなされていない現状がある。本研究は、口腔内細菌叢のメタゲノム解析および口腔内代謝産物のメタボローム解析を用いて頭頸部・食道癌発生および再発に口腔内フローラおよび口腔内代謝産物がもたらす影響を明らかにすることを目的とする。本研究により、将来的に口腔内細菌叢をターゲットにした新規治療法の開発と頭頸部・食道癌発生、進展および再発阻止に寄与する癌予防医学への貢献が期待される。

Outline of Final Research Achievements

The influence of oral microbiota on the development and recurrence of head and neck and esophageal cancer has not been fully investigated. The aim of this study was to elucidate the effects of oral flora and oral metabolites on head and neck and esophageal cancer development and recurrence using metagenomic analysis of oral flora and metabolomics of oral metabolites. samples were collected and changes in oral flora and metabolites were confirmed. This study is expected to contribute to the development of novel therapies targeting the oral microbiota and to cancer prevention medicine that will contribute to the prevention of head and neck and esophageal cancer development, progression, and recurrence in the future.

Academic Significance and Societal Importance of the Research Achievements

頭頸部・食道癌は、同時性および異時性に発生しやすく、飲酒と喫煙が相乗的に多発癌のリスクを高めることが知られている。WHOは「アルコールそのものの発癌性やアルコール代謝産物のアセトアルデヒドが、頭頸部・食道癌の原因となる」と認定しており、分子機序解明に向けた取り組みは急務である。
本研究により、将来的に口腔内細菌叢をターゲットにした新規治療法の開発と頭頸部・食道癌発生、進展および再発阻止に寄与する癌予防医学への貢献が期待される。

Report

(4 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Research-status Report
  • 2019 Research-status Report
  • Research Products

    (34 results)

All 2022 2021 2020 2019 Other

All Journal Article (4 results) (of which Peer Reviewed: 4 results,  Open Access: 1 results) Presentation (27 results) (of which Int'l Joint Research: 9 results) Remarks (3 results)

  • [Journal Article] 膵神経内分泌腫瘍術後5年目に発生した胃mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN)の1例2022

    • Author(s)
      白川智沙斗、三野和宏、深澤拓夢、中積宏之、木村太一、堂本英治、川村秀樹
    • Journal Title

      日本消化器病学会誌

      Volume: 119(3) Pages: 245-250

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A Phase I Trial of Oxaliplatin, Irinotecan, and S-1 Combination Therapy (OX-IRIS) as Chemotherapy for Unresectable Pancreatic Cancer (HGCSG 1403)2021

    • Author(s)
      Kawamoto Yasuyuki、Nakatsumi Hiroshi、Harada Kazuaki、Muranaka Tetsuhito、Ishiguro Atsushi、Kobayashi Yoshimitsu、Hayashi Hideyuki、Yuki Satoshi、Sawada Kentaro、Yagisawa Masataka、Nakano Shintaro、Sakamoto Naoya、Komatsu Yoshito
    • Journal Title

      The Oncologist

      Volume: 26 Issue: 10 Pages: 1675-1682

    • DOI

      10.1002/onco.13838

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Association between the use of antibiotics and efficacy of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer2020

    • Author(s)
      Nakano Shintaro、Komatsu Yoshito、Kawamoto Yasuyuki、Saito Rika、Ito Ken、Nakatsumi Hiroshi、Yuki Satoshi、Sakamoto Naoya
    • Journal Title

      Medicine

      Volume: 99 Issue: 39 Pages: e22250-e22250

    • DOI

      10.1097/md.0000000000022250

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Impact of single-heterozygous UGT1A1 on the clinical outcomes of irinotecan monotherapy after fluoropyrimidine and platinum-based combination therapy for gastric cancer: a multicenter retrospective study2020

    • Author(s)
      Nakano Shintaro、Yuki Satoshi、Kawamoto Yasuyuki、Nakatsumi Hiroshi、Ando Takayuki、Kajiura Shinya、Yoshikawa Ayumu、Harada Kazuaki、Hatanaka Kazuteru、Tanimoto Aya、Ishiguro Atsushi、Honda Takuya、Dazai Masayoshi、Sasaki Takahide、Sakamoto Naoya、Komatsu Yoshito
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 25 Issue: 10 Pages: 1800-1806

    • DOI

      10.1007/s10147-020-01720-y

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Presentation] 新型コロナウイルス感染症の流行が消化器癌薬物療法の運用に及ぼした影響についての単施設後ろ向き調査2022

    • Author(s)
      中積宏之、加藤茜、曽根孝之、大原正嗣、伊藤淳、多谷容子、馬場麗、齋藤智哉、吉田拓人、小丹枝裕二、三野和宏、川村秀樹、清水勇一
    • Organizer
      第19回日本臨床腫瘍学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Multicenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancer (HGCSG1902)2022

    • Author(s)
      Yokoyama T, Ito K, Yuki S, Nakatsumi H, Ando T, Sawada K, Yagisawa M, Ishiguro A, Dazai M, Iwanaga I, Hatanaka K, Sato A, Matsumoto R, Shindo Y, Tateyama M, Muranaka T, Katagiri M, Yokota I, Sakata Y, Komatsu Y.
    • Organizer
      第19回日本臨床腫瘍学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] がん性心膜炎を合併した胃GISTの1例2022

    • Author(s)
      金光雄哉、中積宏之、曽根孝之、大原正嗣、伊藤淳、多谷容子、馬場麗、石田雄一、清水勇一
    • Organizer
      第130回日本消化器病学会北海道支部例会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Ehlers Danlos Syndromeに起因した腹腔内気腫を繰り返した1例2021

    • Author(s)
      西谷高広、加藤貴司、加藤茜、江上太基、伊藤淳、多谷容子、中積宏之、馬場麗、宮下憲暢、松島理明
    • Organizer
      第292回日本内科学会北海道地方会
    • Related Report
      2021 Annual Research Report
  • [Presentation] HGCSG1901:切除不能結腸直腸癌におけるIRIS/Bevの後方視的研究:二次治療例の検討2021

    • Author(s)
      畑中一映、結城敏志、伊藤憲、山村貴洋、八木澤允貴、澤田憲太郎、石黒敦、武藤理、中積宏之、植田亮、舘山美樹、曽我部進、松本隆祐、坂田優、小松嘉人
    • Organizer
      第58回日本癌治療学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] HGCSG1901: a retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: analysis of first line treatment.2021

    • Author(s)
      Ito K, Yuki S, Nakano S, Yagisawa M, Sawada K, Ishiguro A, Muto O, Hatanaka K, Okuda H, Sato A, Sasaki Y, Nakamura M, Sasaki T, Kobayashi T, Dazai M, Nakatsumi H, Ueda A, Tateyama M, Sogabe S, Matsumoto R, Sakata Y, Komatsu Y.
    • Organizer
      2021 ESMO World Congress on Gastrointestinal Cancer
    • Related Report
      2021 Annual Research Report
    • Int'l Joint Research
  • [Presentation] HGCSG1901: a retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: analysis of second line treatment after anti-EGFR antibody.2021

    • Author(s)
      Yoshikawa A, Ito K, Kawamoto Y, Saito R, Yamamura T, Yagisawa M, Ishiguro A, Muto O, Hatanaka K, Okuda H, Sato A, Sasaki Y, Nakamura M, Sasaki T, Kobayashi T, Dazai M, Nakatsumi H, Ueda A, Sakata Y, Komatsu Y.
    • Organizer
      2021 ESMO World Congress on Gastrointestinal Cancer
    • Related Report
      2021 Annual Research Report
    • Int'l Joint Research
  • [Presentation] HGCSG1902: Multicenter, prospective, observational study for patients with dysgeusia caused by chemotherapy for gastrointestinal cancer.2021

    • Author(s)
      Ito K, Yuki S, Nakatsumi H, Ando T, Sawada K, Yagisawa M, Ishiguro A, Dazai M, Iwanaga I, Hatanaka K, Sato A, Matsumoto R, Shindo Y, Tateyama M, Muranaka T, Katagiri M, Yokota I, Sakata Y, Sakamoto N, Komatsu Y
    • Organizer
      Gastrointestinal Cancers Symposium
    • Related Report
      2021 Annual Research Report
    • Int'l Joint Research
  • [Presentation] The results of the questionnaire survey of oral steroids for patients with cancer-related fatigue2021

    • Author(s)
      山村貴洋、小松嘉人、結城敏志、川本泰之、原田一顕、中野真太郎、伊藤憲、斎藤里佳、小野耕一、畑中一映、澤田憲太郎、石黒敦、中積宏之、進藤吉明、小野寺馨、大沼啓之、上林実、坂本直哉
    • Organizer
      第18回日本臨床腫瘍学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] HGCSG1603: a phase 2 trial of ramucirumab plus irinotecan as second-line treatment for advanced gastric cancer.2021

    • Author(s)
      Sawada K, Kawamoto Y, Yuki S, Nakamura M, Muto O, Sogabe S, Shindo Y, Ishiguro A, Sato A, Tsuji Y, Dazai M, Okuda H, Sasaki T, Harada K, Nakano S, Nakatsumi H, Sekiguchi M, Sakata Y, Sakamoto N, Komatsu Y.
    • Organizer
      第18回日本臨床腫瘍学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] 内視鏡的に切除した長径30mm大の十二指腸ブルンネル腺過形成の1例2021

    • Author(s)
      佐々木耕、加藤茜、江上太基、長島一哲、伊藤淳、多谷容子、中積宏之、馬場麗、加藤貴司、木村太一
    • Organizer
      第122回日本消化器内視鏡学会北海道支部例会
    • Related Report
      2020 Research-status Report
  • [Presentation] ニボルマブ投与で長期生存している胃癌の1例2021

    • Author(s)
      加藤茜、中積宏之、江上太基、長島一哲、伊藤淳、多谷容子、馬場麗、加藤貴司
    • Organizer
      第128回日本消化器病学会北海道支部例会
    • Related Report
      2020 Research-status Report
  • [Presentation] 下部消化管内視鏡検査の前処置にて不幸な転帰をとった3例2021

    • Author(s)
      江上太基、加藤貴司、加藤茜、長島一哲、伊藤淳、多谷容子、中積宏之、馬場麗
    • Organizer
      第122回日本消化器内視鏡学会北海道支部例会
    • Related Report
      2020 Research-status Report
  • [Presentation] Results of a phase 2 trial of ramucirumab plus irinotecan as second-line treatment for patients with advanced gastric cancer (HGCSG1603).2021

    • Author(s)
      Kawamoto Y, Yuki S, Sawada K, Nakamura M, Muto O, Sogabe S, Shindo Y, Ishiguro A, Sato A, Tsuji Y, Dazai M, Okuda H, Sasaki T, Harada K, Nakano S, Nakatsumi H, Sekiguchi M, Sakata Y, Sakamoto N, Komatsu Y.
    • Organizer
      Gastrointestinal Cancers Symposium 2021 Virtual
    • Related Report
      2020 Research-status Report
    • Int'l Joint Research
  • [Presentation] 短期間で0-IIa+IIc型から1型への形態変化をきたした胃癌の1例2020

    • Author(s)
      佐々木耕、長島一哲、加藤茜、中村赳晶、江上太基、伊藤淳、多谷容子、中積宏之、馬場麗、加藤貴司、木村太一、深沢拓夢、白川智沙斗、小丹枝裕二、三野和宏、川村秀樹
    • Organizer
      第121回日本消化器内視鏡学会北海道支部例会
    • Related Report
      2020 Research-status Report
  • [Presentation] A型胃炎に胃神経内分泌腫瘍と早期胃癌を同時性に併発した1例2020

    • Author(s)
      澤山初音、馬場麗、加藤茜、中村赳晶、江上太基、長島一哲、伊藤淳、多谷容子、中積宏之、加藤貴司、木村太一
    • Organizer
      第121回日本消化器内視鏡学会北海道支部例会
    • Related Report
      2020 Research-status Report
  • [Presentation] 胆管プラスチックステント逸脱による十二指腸穿孔の1例2020

    • Author(s)
      加藤茜、多谷容子、中村赳晶、江上太基、長島一哲、伊藤淳、中積宏之、馬場麗、加藤貴司、三野和宏、大場光信、三橋智子
    • Organizer
      第121回日本消化器内視鏡学会北海道支部例会
    • Related Report
      2020 Research-status Report
  • [Presentation] 消化管間質腫瘍(GIST)におけるレゴラフェニブ治療と骨格筋量の変化に関する検討2020

    • Author(s)
      伊藤憲、原田一顕、川本泰之、中積宏之、中野真太郎、斎藤里佳、山村貴洋、結城敏志、小松嘉人、坂本直哉
    • Organizer
      第127回日本消化器病学会北海道支部例会
    • Related Report
      2020 Research-status Report
  • [Presentation] IRIS/Bev療法時の下痢に対する半夏瀉心湯予防投与の第二相試験:生存期間の解析2020

    • Author(s)
      原田一顕、中積宏之、川本泰之、結城敏志、石黒敦、舘山美樹、宮城島拓人、中村路夫、太宰昌佳、奥田博介、畑中一映、天野虎次、小松嘉人
    • Organizer
      第58回日本癌治療学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] 消化器癌の化学療法で味覚異常を発症した症例の多施設共同医師主導前向き観察研究2020

    • Author(s)
      伊藤憲、結城敏志、中積宏之、安藤孝将、太宰昌佳、畑中一映、宮城島拓人、久居弘幸、石黒敦、植田亮、佐々木尚英、進藤吉明、坂本直哉、坂田優、小松嘉人
    • Organizer
      第58回日本癌治療学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] HGCSG1902: multicenter, prospective, observational study for cases with dysgeusia caused by chemotherapy for gastrointestinal cancer.2020

    • Author(s)
      Ando T, Ito K, Yuki S, Saito R, Nakano S, Nakatsumi H, Kawamoto Y, Dazai M, Miyashita K, Hatanaka K, Harada K, Miyagishima T, Hisai H, Ishiguro A, Ueda A, Kato T, Sasaki T, Shindo Y, Yokota I, Takagi R, Sakata Y, Komatsu Y.
    • Organizer
      ESMO World Congress on Gastrointestinal Cancer 2020 VIRTUAL
    • Related Report
      2020 Research-status Report
    • Int'l Joint Research
  • [Presentation] HGCSG1801: a phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer (mCRC) refractory to anti-EGFR antibody.2020

    • Author(s)
      Shindo Y, Nakatsumi H, Yuki S, Kawamoto Y, Muto O, Dazai M, Harada K, Kobayashi Y, Sogabe S, Katagiri M, Kotaka M, Nakamura M, Hatanaka K, Ishiguro A, Tsuji Y, Kobayashi T, Tateyama M, Sasaki Y, Sasaki T, Takagi R, Sakata Y, Komatsu Y.
    • Organizer
      ESMO World Congress on Gastrointestinal Cancer 2020 VIRTUAL.
    • Related Report
      2020 Research-status Report
    • Int'l Joint Research
  • [Presentation] Prognostic value of inflammation-based score for pancreatic cancer patients treated with FOLFIRINOX (FFX) or gemcitabine plus nab-paclitaxel (GnP).2020

    • Author(s)
      Kazuaki Harada, Nakano S, Saito R, Ito K, Nakatsumi H, Kawamoto Y, Yuki S, Sakamoto N, Komatsu Y.
    • Organizer
      ESMO World Congress on Gastrointestinal Cancer 2020 VIRTUAL.
    • Related Report
      2020 Research-status Report
    • Int'l Joint Research
  • [Presentation] Prognostic value of inflammation-based score for pancreatic cancer patients treated with FOLFIRINOX (FFX) or gemcitabine plus nab-paclitaxel (GnP).2020

    • Author(s)
      Yamamura T, Nakano S, Saito R, Ito K, Nakatsumi H, Harada K, Kawamoto Y, Yuki S, Sakamoto N, Komatsu Y.
    • Organizer
      ESMO Asia 2020 Virtual.
    • Related Report
      2020 Research-status Report
    • Int'l Joint Research
  • [Presentation] 切除可能胸部食道扁平上皮癌に対する術前補助化学療法+根治切除術および根治的 化学放射線療法の後方視的検討.2019

    • Author(s)
      中積 宏之、小松 嘉人、坂本 直哉.
    • Organizer
      第105回日本消化器病学会総会.
    • Related Report
      2019 Research-status Report
  • [Presentation] Retrospective analysis of the efficacy and safety of regorafenib in patients with advanced GIST.2019

    • Author(s)
      Nakatsumi H, Komatsu Y, Saito R, Ito K, Nakano S, Kawamoto Y, Yuki S, Sakamoto N.
    • Organizer
      The ESMO 21st World Congress on Gastrointestinal Cancer.
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] Retrospective analysis of the efficacy and safety of regorafenib in patients with advanced GIST.2019

    • Author(s)
      Nakatsumi H, Komatsu Y, Saito R, Ito K, Nakano S, Kawamoto Y, Yuki S, Sakamoto N.
    • Organizer
      第17回日本臨床腫瘍学会学術集会.
    • Related Report
      2019 Research-status Report
  • [Remarks] 北海道大学大学院医学研究院消化器内科学教室

    • URL

      http://halo.med.hokudai.ac.jp/

    • Related Report
      2021 Annual Research Report
  • [Remarks] 北海道大学大学院医学研究院消化器内科学教室ホームページ

    • URL

      http://halo.med.hokudai.ac.jp/

    • Related Report
      2020 Research-status Report
  • [Remarks] 北海道大学大学院医学研究院内科学分野消化器内科学教室

    • URL

      https://halo.med.hokudai.ac.jp/

    • Related Report
      2019 Research-status Report

URL: 

Published: 2019-04-18   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi